Founded in 2009, the Site Solutions Summit Eagle Award™ annually recognizes the sponsor and CRO organizations who are dedicated to creating positive relationships with sites. Through their leadership, professionalism and integrity, these industry leaders work with sites to ensure patient safety, timely enrollment, and effective communication to optimize study success.
Ellicott City, MD, August 25, 2016 – The Society for Clinical Research Sites announces today the finalists for the 2016 SCRS Eagle Award™. The finalists were selected from nominations provided by SCRS members. Qualifying nominees were in the 75th percentile or higher of the total nominations submitted for the Eagle Award. Voting is now open to all clinical research site professionals, regardless of their membership with SCRS, and closes September 21, 2016.
Congratulations to the 2016 sponsor finalists: Amgen, Eli Lilly, GlaxoSmithKline, Merck, Nektar, Novartis, Novo Nordisk, and Pfizer.
Congratulations to the 2016 CRO finalists: INC Research, Medpace, PRA, Quintiles, and Target Health.
“SCRS congratulates each Eagle Award finalist and looks forward to announcing the Sponsor and CRO recipients during the Eagle Award Gala,” said Christine Pierre, President of SCRS. “These nominations signify sites’ eagerness to appreciate and publicly recognize companies demonstrating a strong commitment to the site partnership, which is critical for our collective success.”
The SCRS Eagle Award recognizes outstanding leadership, professionalism, integrity, and dedication to advancing the clinical research profession through a strong site partnership. SCRS Eagle Award nominees are finalized through direct site input. Winners will be honored at the 2016 SCRS Eagle Award Gala on Saturday, October 15th in Boca Raton, Florida during the 11th Annual Global Site Solutions Summit.
Read the press release here.